Tracing the Impact of Amyloid Beta in Mild Cognitive Impairment, University of Melbourne Study

Published: Jan 16, 2013

The amount of amyloid ß (Aß) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's open access journal Alzheimer's Research & Therapy. The non-invasive study which used 18F-florbetaben to find Aß plaques in brain scans to also show that in MCI the affect of Aß on memory loss is independent of other aspects of mental decline.

Back to news